Researchers are banned from looking at gun violence. One physician wants to change that

Abortion rights groups look to next fights after 2022 wins

Resistance to FDA’s opioid-disposal plan raises concerns about CADCA, a powerful advocacy group

PhRMA, once invincible in Washington, has lost its edge